Skip to main content

Dr. Mark N. Hendrixson, MD

Medical Oncology (Medical Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
36
In the NPI registry since
2006
Medicare patients seen, 2024
491

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1990Medical school: University of Tennessee, Hsc, College of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    TN license MD021724

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Where they work

Hospitals

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
491
Services billed
213,225
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, ferric carboxymaltose, 1 mg64,50247
Injection, pembrolizumab, 1 mg17,60011
Injection, denosumab, 1 mg4,74025
Injection, dexamethasone sodium phosphate, 1 mg1,92527
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units1,80016
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count1,677398
Insertion of needle into vein for collection of blood sample1,241381
Injection, ondansetron hydrochloride, per 1 mg94511
Injection, palonosetron hcl, 25 mcg91012
Established patient office or other outpatient visit, 30-39 minutes798369

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 46 companies reported 91 payments worth $2,157 in total to this clinician.

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 3, 2025Seagen Inc.
Sep 3, 2025
Education
in-kind
$91.99
Mar 27, 2025Aveo Pharmaceuticals, Inc.
Mar 27, 2025
Education
FOTIVDA · Oncology · in-kind
$20.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Tennessee →

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 24, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1457469223. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.